Showing results (81-90 of 116) with videos related to
Sort By:
Pageof 12
Oral Oncology|August 16, 2012
Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancerPen-Yuan Chu, Fang-Wei Hu, Cheng-Chia Yu, et al.Archives of Otolaryngology--Head & Neck Surgery|October 22, 2008
Role of chest computed tomography in head and neck cancerYen-Bin Hsu, Pen-Yuan Chu, Juhn-Cherng Liu, et al.Head & Neck|January 31, 2012
Expression of hedgehog signaling molecules as a prognostic indicator of oral squamous cell carcinomaYi-Fen Wang, Chun-Ju Chang, Chin-Ping Lin, et al.Biomed Research International|August 12, 2014
Cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatmentMing-Hung Hu, Ling-Wei Wang, Hsueh-Ju Lu, et al.Head & Neck|November 3, 2005
Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynxKaren Lin, Snehal G Patel, Pen Yuan Chu, et al.Esophagus : Official Journal of the Japan Esophageal Society|January 9, 2024
Routine image-enhanced endoscopic surveillance for metachronous esophageal squamous cell neoplasms in head and neck cancer patientsYong-Cheng Ye, Yen-Po Wang, Tien-En Chang, et al.Journal of the Chinese Medical Association : JCMA|July 9, 2017
The pattern of failure and predictors of locoregional control in lateralized buccogingival cancer after postoperative radiation therapyTzu-Yu Lai, Yu-Wen Hu, Yu-Ming Liu, et al.Journal of the Chinese Medical Association : JCMA|July 26, 2008
Methotrexate and leucovorin double-modulated 5-fluorouracil combined with cisplatin (MPFL) in metastatic/recurrent head and neck cancerPeter Mu-Hsin Chang, Hao-Wei Teng, Po-Min Chen, et al.Cancer Chemotherapy and Pharmacology|March 18, 2008
Effectiveness of pharmacokinetic modulating chemotherapy combined with cisplatin as induction chemotherapy in resectable locally advanced head and neck cancer: phase II studyPeter Mu-Hsin Chang, Po-Min Chen, Pen-Yuan Chu, et al.BMC Cancer|December 20, 2022
Treatment outcomes of cetuximab-containing regimen in locoregional recurrent and distant metastatic head and neck squamous cell carcinomaTien-Hua Chen, Yi-Ying Pan, Tsung-Lun Lee, et al.Pageof 12